Official NAROVAC news and updates
Follow developments in NAROVAC research, field activities, partnerships, events and public information.
Safety Study Results Published in Peer-Reviewed Journal
Comprehensive safety study findings published, confirming the favorable safety profile of NAROVAC in native Ugandan cattle breeds.
Read More
NAROVAC Progresses Toward Market Authorization
Regulatory submission underway as NARO Vaccines and Pharmaceuticals Centre advances toward final market authorization for Uganda's first anti-tick vaccine.
Read MoreReceive NAROVAC updates
Subscribe to receive occasional official news, research and public-information updates.
By subscribing, you agree to receive NAROVAC updates. You can unsubscribe at any time.